PIERRE & VACANCES (VAC.PA)

FR0000073041 - Common Stock

1.716  -0.01 (-0.35%)


Fundamental Rating

4

Overall VAC gets a fundamental rating of 4 out of 10. We evaluated VAC against 19 industry peers in the Hotels, Restaurants & Leisure industry. VAC has a bad profitability rating. Also its financial health evaluation is rather negative. VAC has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination!

Note: VAC has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

2

VAC has a Profit Margin of 17.57%. This is better than the industry average of 12.51%.

VS Industry

Profit Margin (17.57%) VS Industry: 71% outperformed.

3.48
18.76

Valuation

Valuation Rating

8

With a Price/Earnings Ratio of 0.10, the valuation of VAC can be described as very cheap.
Compared to an average industry Price/Earning Ratio of 17.83, VAC is valued rather cheaply. On top of this VAC is cheaper than 100% of the companies listed in the same industry.
VAC's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

When comparing the Enterprise Value to EBITDA ratio of VAC to the average industry ratio of 8.70, VAC is valued rather cheaply. VAC is also cheaper than 91% of the companies listed in the same industry.
With a Forward Price/Earnings Ratio of 24.27, VAC is valued rather expensively.
VS Industry

Price/Earnings (0.1) VS Industry: 100% outperformed.

81.61
0.10

Enterprise Value/ EBITDA (1.55) VS Industry: 91% outperformed.

143.55
0.34

Growth

Growth Rating

9

VAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 559.32%, which is quite impressive.
The Earnings Per Share is expected to grow by 53.73% on average over the next 5 years. This is a very strong growth
Looking at the last year, VAC shows a very strong growth in Revenue. The Revenue has grown by 29.18%.

VAC is expected to show quite a strong growth in Revenue. In the coming 5 years, the Revenue will grow by 10.58% yearly.
The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.
The Revenue has been growing slightly by 2.50% on average over the past 5 years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A 559.32% 168.09% 80.83% 53.73% N/A
Revenue2.5% 0.36% 29.18% 21.17% 14.02% 10.58% N/A

Health

Health Rating

0


VS Industry

Dividend

Dividend Rating

0

No dividends for VAC!.

PIERRE & VACANCES

EPA:VAC (6/8/2023, 5:29:47 PM)

1.716

-0.01 (-0.35%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap779.59M
Analysts82.22
Price Target2.08 (21.21%)
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
PT rev (1m)6.25%
PT rev (3m)15.74%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)232.42%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.06%
Valuation
Industry RankSector Rank
PE 0.1
Fwd PE 24.27
P/S 0.45
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 1.55
EPS(TTM)18
EY1048.95%
EPS(NY)0.07
Fwd EY4.12%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.78
BVpSN/A
TBVpSN/A
PEG (NY)0
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 14.42%
PM 17.57%
GM 66.88%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y136.42%
OM growth 5Y44.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.13%
GM growth 5Y1.14%
F-ScoreN/A
Asset TurnoverN/A
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACC3.33%
ROIC/WACCN/A
Cap/Depr(3y)17%
Cap/Depr(5y)72.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y559.32%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-21.49%
EPS Next Y168.09%
EPS Next 2Y80.83%
EPS Next 3Y53.73%
EPS Next 5YN/A
Revenue growth 1Y29.18%
Revenue growth 3Y0.36%
Revenue growth 5Y2.5%
Revenue growth Q2Q16.5%
Revenue Next Year21.17%
Revenue Next 2Y14.02%
Revenue Next 3Y10.58%
Revenue Next 5YN/A
EBIT growth 1Y27.12%
EBIT growth 3Y137.28%
EBIT growth 5Y48.57%
EBIT Next Year186.27%
EBIT Next 3Y55.02%
EBIT Next 5YN/A
FCF growth 1Y842.81%
FCF growth 3Y432.38%
FCF growth 5Y161.58%
OCF growth 1Y2703.35%
OCF growth 3Y65.39%
OCF growth 5Y49.94%
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the EuroNext

Screen Image

Growth Stock Screener

Find more growth stocks the EuroNext

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the EuroNext

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the EuroNext

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the EuroNext